Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Dyer

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
The Journal of Physical Chemistry. B|July 21, 2006
Quantum delocalization of hydrogen in the Li2NH crystalChangjun Zhang, Matthew Dyer, Ali Alavi
Gynecologic Oncology|February 2, 2019
Targeted surgical prevention of epithelial ovarian cancer is cost effective and saves money in BRCA mutation carrying family members of women with epithelial ovarian cancer. A Canadian modelPaul Hoskins, Anthony Eccleston, Manjusha Hurry, et al.
International Journal of Technology Assessment in Health Care|May 20, 2020
Canadian cost-effectiveness model of BRCA-driven surgical prevention of breast/ovarian cancers compared to treatment if cancer developsManjusha Hurry, Anthony Eccleston, Matthew Dyer, et al.
Current Protocols|April 25, 2025
Leveraging the MethMotif Toolkit to Characterize Context-Specific Features and Roles of Methylation Sensitive Transcription FactorsMatthew Dyer, Gastongay Siu, Denis Thieffry, et al.
Nature Protocols|October 1, 2025
NanoVar: a comprehensive workflow for structural variant detection to uncover the genome's hidden patternsAsmaa Samy, Cheng Yong Tham, Matthew Dyer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 5, 2022
An Analysis of 5-Level Version of EQ-5D Adjusting for Treatment Switching: The Case of Patients With Epidermal Growth Factor Receptor T790M-Positive Nonsmall Cell Lung Cancer Treated With OsimertinibJeshika Singh, Siobhan Bourke, Matthew Dyer, et al.
Chronic Respiratory Disease|January 21, 2011
The effect of COPD health forecasting on hospitalisation and health care utilisation in patients with mild-to-moderate COPDN D Bakerly, June A Roberts, Anna R Thomson, et al.
Health Economics Review|April 23, 2020
The validation of published utility mapping algorithms: an example of EORTC QLQ-C30 and EQ-5D in non-small cell lung cancerJoanne Gregory, Matthew Dyer, Christopher Hoyle, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 4, 2009
The precision of health state valuation by members of the general public using the standard gambleKen Stein, Matthew Dyer, Ruairidh Milne, et al.
Journal of Medical Economics|September 8, 2017
Cost-effectiveness of osimertinib in the UK for advanced EGFR-T790M non-small cell lung cancerEvelina Bertranou, Carolyn Bodnar, Viktor Dansk, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
The Journal of Physical Chemistry. B|July 21, 2006
Quantum delocalization of hydrogen in the Li2NH crystalChangjun Zhang, Matthew Dyer, Ali Alavi
Gynecologic Oncology|February 2, 2019
Targeted surgical prevention of epithelial ovarian cancer is cost effective and saves money in BRCA mutation carrying family members of women with epithelial ovarian cancer. A Canadian modelPaul Hoskins, Anthony Eccleston, Manjusha Hurry, et al.
International Journal of Technology Assessment in Health Care|May 20, 2020
Canadian cost-effectiveness model of BRCA-driven surgical prevention of breast/ovarian cancers compared to treatment if cancer developsManjusha Hurry, Anthony Eccleston, Matthew Dyer, et al.
Current Protocols|April 25, 2025
Leveraging the MethMotif Toolkit to Characterize Context-Specific Features and Roles of Methylation Sensitive Transcription FactorsMatthew Dyer, Gastongay Siu, Denis Thieffry, et al.
Nature Protocols|October 1, 2025
NanoVar: a comprehensive workflow for structural variant detection to uncover the genome's hidden patternsAsmaa Samy, Cheng Yong Tham, Matthew Dyer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 5, 2022
An Analysis of 5-Level Version of EQ-5D Adjusting for Treatment Switching: The Case of Patients With Epidermal Growth Factor Receptor T790M-Positive Nonsmall Cell Lung Cancer Treated With OsimertinibJeshika Singh, Siobhan Bourke, Matthew Dyer, et al.
Chronic Respiratory Disease|January 21, 2011
The effect of COPD health forecasting on hospitalisation and health care utilisation in patients with mild-to-moderate COPDN D Bakerly, June A Roberts, Anna R Thomson, et al.
Health Economics Review|April 23, 2020
The validation of published utility mapping algorithms: an example of EORTC QLQ-C30 and EQ-5D in non-small cell lung cancerJoanne Gregory, Matthew Dyer, Christopher Hoyle, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 4, 2009
The precision of health state valuation by members of the general public using the standard gambleKen Stein, Matthew Dyer, Ruairidh Milne, et al.
Journal of Medical Economics|September 8, 2017
Cost-effectiveness of osimertinib in the UK for advanced EGFR-T790M non-small cell lung cancerEvelina Bertranou, Carolyn Bodnar, Viktor Dansk, et al.
Pageof 3